Featured Research

from universities, journals, and other organizations

Fertility therapy not associated with long-term cardiovascular disease

Date:
July 31, 2013
Source:
Women's College Hospital
Summary:
Women who gave birth following fertility treatment had no long-term increased risk of death or major cardiovascular events compared to women who gave birth without fertility therapy, according to new research.

Women who gave birth following fertility treatment had no long-term increased risk of death or major cardiovascular events compared to women who gave birth without fertility therapy, according to new research by the Institute for Clinical Evaluative Sciences (ICES) and Women's College Hospital.

The findings, published today in the Journal of the American College of Cardiology, are the first to show fertility medications, which can cause short-term pregnancy complications, are not associated with an increased risk of cardiovascular disease later in life.

"The speculated association between fertility therapy and subsequent cardiovascular disease is not surprising given that more women are waiting until an older age to have children, when they are at greater risk of developing heart disease," said Dr. Jacob Udell, lead author of the study and cardiologist at Women's College Hospital.

Fertility therapy is used in nearly one percent of all successful pregnancies in North America. But these medications are known to cause short-term complications such as gestational diabetes and hypertension. These short-term risks, however, do not translate into lasting cardiovascular damage according to the researchers.

In the study, researchers assessed the long-term risk of stroke, heart attack and heart failure following fertility therapy among 1.1 million women after delivery over a 17-year follow-up period in Ontario. They found:

  • A five-fold increase in the use of fertility therapy from 1993 to 2010, particularly among older women.
  • The use of fertility therapy was associated with an increase in pregnancy complications including a near 30 per cent increase of diabetes in pregnancy, 16 per cent increase in placental disorders and a 10 per cent increase in pre-eclampsia.
  • Women who delivered following fertility therapy had about half the risk of subsequent death compared to women who did not have fertility therapy.
  • Women who delivered following fertility therapy had nearly half the risk of major cardiovascular events such as stroke, heart attack and heart failure. The researchers do not believe that this is a direct effect of treatment; rather that women undergoing fertility therapy maintain a healthy lifestyle over a long period.
  • Researchers reported no increase in the risk of future breast or ovarian cancer in women who gave birth following fertility therapy.
  • Women who had fertility therapy also experienced fewer mental health events, including one-third the rate of depression and one-sixth the rate of self-harm.

"Our findings provide some reassurance that fertility therapy does not appear to increase long-term risk of cardiovascular events following successful pregnancy," says Dr. Donald Redelmeier, co-author of the study and a senior scientist at ICES. "The existing literature provides mixed messages, with our results yielding a relatively favourable assessment."

One theory is that women who seek fertility therapy maintain healthier behavior after a successful delivery -- a pattern that extends across age and income groups, the researchers say. "Those with successful outcomes may have a powerful and durable change to their lifestyle," says Dr. Redelmeier. "Unknown protective mechanism may also contribute."

"Our findings are encouraging but further research is necessary to explain the full impact of fertility therapy on women's health," Dr. Udell adds. "With a better understanding of the long-term health effects associated with fertility therapy, we can help inform decision making and reduce potential health risks to women."


Story Source:

The above story is based on materials provided by Women's College Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jacob A. Udell, Hong Lu, Donald A. Redelmeier. Long Term Cardiovascular Risk in Women Prescribed Fertility Therapy. Journal of the American College of Cardiology, 2013; DOI: 10.1016/j.jacc.2013.05.085

Cite This Page:

Women's College Hospital. "Fertility therapy not associated with long-term cardiovascular disease." ScienceDaily. ScienceDaily, 31 July 2013. <www.sciencedaily.com/releases/2013/07/130731230131.htm>.
Women's College Hospital. (2013, July 31). Fertility therapy not associated with long-term cardiovascular disease. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/07/130731230131.htm
Women's College Hospital. "Fertility therapy not associated with long-term cardiovascular disease." ScienceDaily. www.sciencedaily.com/releases/2013/07/130731230131.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins